Doro AB

  • ISIN: SE0000215493
  • Land: .

Nachricht vom 21.03.2012 | 17:00

Bulletin from Doro AB’s Annual General Meeting 2012


Doro AB 

21.03.2012 17:00
---------------------------------------------------------------------------

Lund, Sweden, 2012-03-21 17:00 CET (GLOBE NEWSWIRE) -- 

At the Annual General Meeting of Doro AB (publ), held on 21 March 2012, it was
resolved, inter alia: 

* to adopt the income statement and balance sheet, and the consolidated income
statement and the consolidated balance sheet; 
* to distribute a dividend of SEK 1 per share for the financial year 2011;
* to discharge from liability the members of the board of directors and the CEO
for the financial year 2011; 
* to re-elect Bo Kastensson, Karin Moberg, Jonas Mårtensson, Jérôme Arnaud and
Charlotta Falvin as members of the board of directors for the period up to and
including the next annual general meeting; 
* to re-elect Bo Kastensson as the chairman of the board of directors;
* remuneration to the board as follows: the chairman receives SEK 350,000 and
other members not employed by the company receive SEK 150,000 each; 
* to adopt principles for the appointment of the nomination committee;
* to authorize the board, for the period until the next annual general meeting,
to resolve, on one or several occasions, to issue not more than 1,930,000
shares without preferential rights for the shareholders. Such new issue
resolution shall include a provision that new shares shall be paid in kind; and 
* to adopt remuneration guidelines with the principal effect that salaries and
other terms of remuneration for the group management shall be on market terms. 



For more information, please contact:
President and CEO Jérôme Arnaud, +46 (0)46 280 50 05,
or Vice President and CFO Annette Borén, +46 (0)706 30 00 09.

This is information that Doro AB (publ) is required to publish in accordance
with the Swedish Securities Markets Act and/or the Swedish Financial Trading
Act. This information was submitted for publication on March 21, 2012 at 5 p.m
CET.
News Source: NASDAQ OMX



21.03.2012 Dissemination of a Corporate News, transmitted by DGAP - 
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Doro AB
              
               
              Sweden
Phone:        
Fax:          
E-mail:       
Internet:     
ISIN:         SE0000215493
WKN:          
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------

GBC-Fokusbox

CytoTools vor Einführung von DermaPro

Die Markteinführung des Hauptproduktes DermaPro steht bei der CytoTools AG kurz bevor. Wir rechnen bereits 2014 mit den ersten Produktionserlösen und 2015 mit den ersten Vermarktungserlösen. Zusätzliche Marktpotenziale werden dabei durch die Ausweitung auf weitere Indikationsgebiete erschlossen. Bei einem fairen Wert je Aktie von 73,30 € lautet unser Rating KAUFEN.

News im Fokus

adidas AG: adidas AG aktualisiert Ausblick angesichts der jüngsten Entwicklungen in Russland/GUS sowie der anhaltenden Schwäche des Golfmarkts und gibt strategische Maßnahmen bekannt, um Wachstum sicherzustellen und voranzutreiben

31. Juli 2014, 08:45

Aktueller Webcast

Fresenius Medical Care AG & Co. KGaA

Q2 2014 Conference Call

31. Juli 2014

Aktuelle Research-Studie

Evotec AG

Original-Research: Evotec AG (von Montega AG): Halten

31. Juli 2014